The technical complexity of determining the serovar of Chlamydia trachomatis strains has limited the use of serotyping in clinical and epidemiologic studies. We developed a simple method for rapidly serotyping isolates of C. trachomatis by using monoclonal antibodies in a dot-enzyme-linked immunosorbent assay (ELISA) system. Isolates were passaged three to six times in shell vial cultures to >50% monolayer infection, and chlamydial elementary bodies were isolated by sonication and microcentrifugation. Chlamydial antigen was spotted onto a series of replicate nitrocellulose membrane patches and reacted with C. trachomatis-specific monoclonal antibodies. Bound antibody was detected visually by a color reaction by using peroxidaseconjugated anti-mouse immunoglobulins. This method can be routinely applied to 60 or more specimens concurrently. We compared dot-ELISA serotyping with monoclonal antibody microimmunofluorescence serotyping of 124 clinical C. trachomatis isolates and found that dot-ELISA has sensitivity and serotyping accuracy comparable to that of monoclonal antibody microimmunofluorescence.
Chlamydia trachomatis causes a broad spectrum of clinical manifestations ranging from localized ocular or genital disease to more invasive infections such as pelvic inflammatory disease, epididymitis, proctocolitis, and infant pneumonitis (2, 4, 14, 16, 17) . Attempts to correlate clinical presentation with specific phenotypic markers of C. trachomatis have to date been limited by the lack of such markers. Patterns of infectivity have allowed the definition of trachoma, lymphogranuloma venereum, and mouse biovars (15) . Organisms of the lymphogranuloma venereum biovar have generally been associated with more severe and invasive disease.
Serotyping has been used to characterize C. trachomatis isolates since the 1960s, first with a bioassay based on serovar-specific prevention of toxic death after intravenous chlamydial challenge in mice (3, 20) and later with an indirect microimmunofluorescence (micro-IF) method employing polyvalent mouse antiserum (21, 24) . The latter method defined 15 chlamydial serovars during the first decade of chlamydial serotyping (1, 12, (21) (22) (23) . However, the micro-IF method has not been widely used in large-scale epidemiologic studies owing to its expense and technical difficulty. Recently, Wang and co-workers (S. P. Wang, C. C. Kuo, R. C. Barnes, R. S. Stephens, and J. T. Grayston, Program Abstr. 24th Intersci. Conf. Antimicrob. Agents Chemother., abstr. no. 152, 1984) described a panel of monoclonal antibodies that have been used in an indirect micro-IF serotyping assay (MA micro-IF). MA micro-IF is more rapid and easier to interpret than conventional micro-IF and does not require the immunization of mice for each isolate. However, MA micro-IF still requires equipment and personnel for detailed fluorescence microscopy.
In this report we describe a method that uses these monoclonal antibodies in a solid-phase enzyme immunoassay of the dot-enzyme-linked immunosorbent assay (ELISA) type (6, 8) . This serotyping system is rapid, simple, easy to interpret, and well suited for the simultaneous serotyping of numerous isolates. . Chlamydia psittaci meningopneumonitis (Mn) strain was included as a negative control. Elementary bodies from each strain were produced in HeLa 229 cell culture (11) and purified by Renografin gradient sedimentation (9) .
Monoclonal antibody production. Hybridoma cell lines were produced by fusing splenocytes from 4-to 6-week-old BALB/c mice, immunized intravenously with purified elementary bodies of C. trachomatis, with murine myeloma cells NS-1 or NS-0 (obtained from C. Milstein, Medical Research Council, Cambridge, England). Details of hybridoma production, antibody screening, and hybridoma cloning were described previously (10, 19) . The serovar specificities of the monoclonal antibodies were determined during production by micro-IF, the conventional ELISA in 96-well plates, and the dot-ELISA. Twenty monoclonal antibodies were used in dot-ELISA typing. Serovar specificities of these antibodies in the dot-ELISA are shown in Table 1 .
C. trachomatis isolation. Clinical specimens for C. trachomatis culture were obtained from rectal and cervical sites of patients attending a clinic for sexually transmitted diseases. Specimens were collected on swabs and transported in 2-SP medium (7) at 4°C as previously described (25) . Specimens were inoculated onto cycloheximide-treated McCoy cell monolayers in 96-well plates (25) . After centrifugation at 3,000 x g at 25°C for 1 h, the specimen was aspirated, and infected cells were fed with minimal essential medium supplemented with glucose and glutamine and containing 10% fetal bovine serum (25) . After 48 to 72 h of incubation at 35°C, chlamydial inclusions were detected by a direct fluorescent monoclonal antibody method (18) . Clinical specimens which produced inclusions in microtiter culture were passaged on monolayers grown on glass cover slips (12 mm). Serial passage was performed until 50 to 100% infected monolayers were obtained (three to six passages). At 48 h after infection, vials were observed with an inverted microscope. Vials containing >50% infected monolayers as indicated by the presence of cytoplasmic refractile cellular inclusions characteristic of C. trachomatis were used for chlamydial antigen preparation.
For preparation of the C. trachomatis antigen used in the dot-ELISA, a single shell vial of C. trachomatis-infected cells was briefly sonicated in a safety hood. The culture medium containing suspended C. trachomatis and host-cell debris was centrifuged at 11,000 x g for 15 min chester, Pa.) was then used to cover each NC square. The conjugate reaction was allowed to proceed at room temperature for 1 h with gentle rotation. The conjugate solution was removed, and the NC squares were washed with four cycles of PBS-Tween and then briefly with PBS. Enzyme-tagged immunoglobulin complexed to C. trachomatis-specific monoclonal antibodies was detected by a colorimetric reaction by using a solution of 4-chloro-1-naphthol (Sigma; 0.5 mg/ml) and hydrogen peroxide (0.025%) in PBS. The 4-chloro-1-naphthol was dissolved in absolute methanol at 3 mg/ml before dilution in PBS. Standard antigens included in each assay were observed closely to determine optimal color development (usually 5 to 10 min), and color development was stopped by rinsing with water.
After being rinsed, the NC squares were dried overnight at room temperature. Each antigen dot was semiquantitatively scored for color production (0, +/-, +, + +, + + +, + + + +), with a 0 signal being no color change, +/-being barely visible change from control, + being light gray, + + being medium gray, + + + being dark gray, and + + + + being jet black. Serovar determination was made by comparing the reaction pattern of the isolate to be typed with the pattern of the prototype antigens included with each assay.
Comparison The ease with which dot-ELISA results may be read is apparent in Fig. 1 
